Pancreatic Cancer Research

ResearcherXiangya Hospital Central South UniversityNo recent work listed

Yixiong Li

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. Chinese herb derived-Rocaglamide A is a potent inhibitor of pancreatic cancer cells. First author PMID 27158390↗
  2. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine. Last author DOI 10.3892/or.2013.2246↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhan-Xiang Xiao · 1 shared paper, 2016 · strength 0.08
  2. Baochun Wang · 1 shared paper, 2016 · strength 0.08
  3. Jianlin Song · 1 shared paper, 2013 · strength 0.05
  4. Xiaoping Yi · 1 shared paper, 2013 · strength 0.05
  5. Liping Cao · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.